DVA vs OCUL · P/E 14, rev $12.82B vs rev $63.7M
DaVita HealthCare Partners Inc (DVA) versus Ocular Therapeutix Inc (OCUL) — a side-by-side from cached financials, not a winner call.
DaVita HealthCare Partners Inc (DVA) is a medical care facilities company listed on US.
Ocular Therapeutix Inc (OCUL) is a biotechnology company listed on US.
Latest reported DVA revenue for 2024-12-31 was $12.82B. Net income was $1.25B. Revenue was up 5.6% from 2023-12-31 to 2024-12-31. DVA currently screens at market cap $10.77B and trailing P/E 14.1.
Latest reported OCUL revenue for 2024-12-31 was $63.7M. Net income was -$193.5M. Revenue was up 9.0% from 2023-12-31 to 2024-12-31. OCUL currently screens at market cap $1.76B.
DVA currently screens at market cap $10.77B and trailing P/E 14.1. OCUL currently screens at market cap $1.76B.
Not investment advice. Open the DVA and OCUL stock pages for the full models.
Not investment advice.